This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT06058377
Brief Title: Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

First Submitted : September 27, 2023
First Submitted that Met QC Criteria : September 27, 2023
First Posted : September 28, 2023

Last Update Submitted that Met QC Criteria : April 17, 2024
Last Update Posted : April 18, 2024